How chitin interacts with the immune system of plants and animals has been an active area of research, including the identity of key receptors with which chitin interacts, whether the size of chitin particles is relevant to the kind of immune response triggered, and mechanisms by which immune systems respond. Chitin is deacetylated  chemically or enzymatically to produce chitosan, a highly biocompatible polymer which has found a wide range of applications in the biomedical industry. Chitin and chitosan have been explored as a vaccine adjuvant due to its ability to stimulate an immune response.
Chitin and chitosan are under development as scaffolds in studies of how tissue grows and how wounds heal, and in efforts to invent better bandages, surgical thread, and materials for allotransplantation. Sutures made of chitin have been experimentally developed, but their lack of elasticity and problems making thread have prevented commercial success so far.
Chitosan has been demonstrated and proposed to make a reproducible form of biodegradable plastic. Chitin nanofibers are extracted from crustacean waste and mushrooms for possible development of products in tissue engineering, drug delivery and medicine.
Chitin has been proposed for use in building structures, tools, and other solid objects from a composite material, combining chitin with Martian regolith. To build this, the biopolymers in the chitin are suggested as the binder for the regolith aggregate to form a concrete-like composite material. The authors believe that waste materials from food production (e.g. scales from fish, exoskeletons from crustaceans and insects, etc.) could be put to use as feedstock for manufacturing processes.